Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 23, 2014

Primary Completion Date

September 26, 2016

Study Completion Date

July 6, 2020

Conditions
Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck
Interventions
DRUG

MEDI4736

MEDI4736 monotherapy

Trial Locations (108)

1090

Research Site, Brussels

1122

Research Site, Budapest

1162

Research Site, Budapest

3000

Research Site, Leuven

3756

Research Site, Lebanon

5000

Research Site, Namur

5700

Research Site, Gyula

6010

Research Site, Batumi

6110

Research Site, Montigny-le-Tilleul

8500

Research Site, Kortrijk

10037

Research Site, New York

10408

Research Site, Goyang-si

10449

Research Site, Taipei

11795

Research Site, Stony Brook

12200

Research Site, Berlin

14215

Research Site, Buffalo

16247

Research Site, Suwon

21079

Research Site, Dijon

21201

Research Site, Baltimore

21204

Research Site, Baltimore

22031

Research Site, Fairfax

22190

Research Site, Plerin SUR MER

26506

Research Site, Morgantown

27710

Research Site, Durham

28041

Research Site, Madrid

28046

Research Site, Madrid

28050

Research Site, Madrid

29010

Research Site, Málaga

29229

Research Site, Brest

29600

Research Site, Marbella (Málaga)

30912

Research Site, Augusta

31008

Research Site, Pamplona

31059

Research Site, Toulouse

31096

Research Site, Haifa

31201

Research Site, Macon

32207

Research Site, Jacksonville

33000

Research Site, Bordeaux

34298

Research Site, Montpellier

35768

Research Site, Saint-Grégoire

37332

Research Site, Nashville

38138

Research Site, Germantown

42601

Research Site, Daegu

46014

Research Site, Valencia

46026

Research Site, Valencia

48075

Research Site, Southfield

48903

Research Site, Barakaldo

49933

Research Site, Angers

50009

Research Site, Zaragoza

52621

Research Site, Tel Litwinsky

53226

Research Site, Milwaukee

55407

Research Site, Minneapolis

56322

Research Site, Lorient

59020

Research Site, Lille

59100

Research Site, Kuala Lumpur

60201

Research Site, Evanston

63011

Research Site, Clermont-Ferrand

63110

Research Site, St Louis

67085

Research Site, Strasbourg

69120

Research Site, Heidelberg

69373

Research Site, Lyon

72000

Research Site, Le Mans

75230

Research Site, Dallas

76021

Research Site, Rouen

78701

Research Site, Austin

80045

Research Site, Denver

81377

Research Site, München

85364

Research Site, Yuma

88996

Research Site, Sabak Bernam

90025

Research Site, Los Angeles

90089

Research Site, Los Angeles

90095

Research Site, Los Angeles

90602

Research Site, Whittier

90813

Research Site, Long Beach

91010

Research Site, Duarte

92835

Research Site, Fullerton

93586

Research Site, Kuching

94115

Research Site, San Francisco

94805

Research Site, Villejuif

97213

Research Site, Portland

4941492

Research Site, Petah Tikva

35294-3300

Research Site, Birmingham

40536-0001

Research Site, Lexington

02215

Research Site, Boston

48109-5000

Research Site, Ann Arbor

55905-0001

Research Site, Rochester

27157-1023

Research Site, Winston-Salem

T2N 2T9

Research Site, Calgary

N6A 4L6

Research Site, London

K1H 8L6

Research Site, Ottawa

M5G 2M9

Research Site, Toronto

H4A 3J1

Research Site, Montreal

762 75

Research Site, Zlín

06189

Research Site, Nice

0144

Research Site, Tbilisi

0177

Research Site, Tbilisi

0179

Research Site, Tbilisi

06120

Research Site, Halle

04103

Research Site, Leipzig

03080

Research Site, Seoul

08025

Research Site, Barcelona

08035

Research Site, Barcelona

08036

Research Site, Barcelona

08907

Research Site, L'Hospitalet de Llobregat

B15 2TH

Research Site, Birmingham

G12 0YN

Research Site, Glasgow

E1 1BB

Research Site, London

M20 4BX

Research Site, Manchester

CH63 4JY

Research Site, Metropolitan Borough of Wirral

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

AstraZeneca

INDUSTRY